NPC’s comments to the Department of Health and Human Services' Request for Information recommend that the application of anti-kickback statute to value-based contracts should be clarified in a manner that supports the transition to value-based reimbursement.

In an interview with NPC, Lindsay Videnieks, director of the Headache and Migraine Policy Forum, discusses the kind of effort it takes to become involved in the ICER value assessment process, what her organization learned along the way and how ICER’s patient engagement process could be improved.

In his latest column for Specialty Pharmacy Times, NPC President and Chief Executive Officer Dan Leonard explores research published in Health Affairs that sheds light on when and how payers cover specialty medications.